- Processing Solutions
- Agitators
- Asset Management
- Automation
- Blowers & Fans
- Centrifuges
- Chillers
- Compressors
- Conveyors
- Dryers & Evaporators
- Feeders
- Filtration & Separation
- Flowmeters
- Fluid Flow
- Heat Exchangers
- Instrumentation
- Level Measurement
- Maintenance & Safety
- Mixing & Blending
- Motors & Drives
- Oil Skimmers
- Piping & Tubing
- Packaging Equipment
- Powder & Bulk Solids
- Process Control
- Pumps & Seals
- Size Reduction
- Tanks & Vessels
- Valves & Actuators
- Weighing
- More
- Newsletters
- White Papers
- Buyer's Guide
- Videos
- Events
- Advertise
More
Drug maker Cephalon Inc. reported recently its plans to close a facility in Eden Prairie, Minn., and consolidate other research and development activities, resulting in the elimination of about 90 positions, according to the Associated Press.
Cephalon plans to move manufacturing activities at its CIMA Labs Inc. facility in Eden Prairie to the company''s recently expanded facility in Salt Lake City. The company will also move certain research and development activities currently performed in Salt Lake City to CIMA''s facility in Brooklyn Park, Minn.
The Frazer, Pa.-based company said it expects to eliminate about 170 jobs at CIMA and add about 80 jobs in Salt Lake City -- resulting in the total elimination of about 90 positions. Cephalon said the restructuring is intended to increase the efficiency of manufacturing and research and development, reduce the company''s cost structure, and improve competitiveness. The company said the closure of the Eden Prairie facility and manufacturing transition is expected to be completed within two to three years. The consolidation of research and development activities at Brooklyn Park is expected to be completed in 2008.
Cephalon plans to move manufacturing activities at its CIMA Labs Inc. facility in Eden Prairie to the company''s recently expanded facility in Salt Lake City. The company will also move certain research and development activities currently performed in Salt Lake City to CIMA''s facility in Brooklyn Park, Minn.
The Frazer, Pa.-based company said it expects to eliminate about 170 jobs at CIMA and add about 80 jobs in Salt Lake City -- resulting in the total elimination of about 90 positions. Cephalon said the restructuring is intended to increase the efficiency of manufacturing and research and development, reduce the company''s cost structure, and improve competitiveness. The company said the closure of the Eden Prairie facility and manufacturing transition is expected to be completed within two to three years. The consolidation of research and development activities at Brooklyn Park is expected to be completed in 2008.
